Quantcast

Sign Up For Email Updates:

       Please leave this field empty

From Our Blog

More from the blog »
WCRF/AICR
Global Network

Epigallocatechin-3-gallate for Enhancement of Cisplatin Therapy (2006)

Title:

Epigallocatechin-3-gallate for Enhancement of Cisplatin Therapy

Key words:

green tea, EGCG, cisplatin, AP-1, NF-?B, glutathione

Research Institution:

Temple University

Location:

Pennsylvania

Researcher:

Marion M Chan

Project Description:

This study determined whether EGCG, a major component of green tea, sensitises ovarian cancer cells to cisplatin treatment by inhibiting detoxifcation of cisplatin through inactivation of AP-1 and NF-?B pathways that could lead to the depletion of glutathione.

Cancer Site(s)

Related Foods that Fight Cancer

Questions: Ask Our Staff

Talk to us!

Our planned giving staff is
here to help you!

Ann Wrenshall Worley

Ann Wrenshall Worley

Assistant Director of Planned Giving

Call Us: (800) 843-8114

Send us a note